STOCK TITAN

[Form 4] Axon Enterprise, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Brooks Cameron, Chief Revenue Officer of Axon Enterprise, reported a transaction on 09/02/2025 disposing of 749 shares of Axon common stock. The Form 4 states the shares were withheld to satisfy the reporting person’s tax liability from the vesting of restricted stock units, at a price of $747.29 per share. After the withholding, the reporting person beneficially owned 18,698 shares, held directly. The form was signed by an attorney-in-fact on 09/03/2025. No other transactions or derivative positions are reported.

Brooks Cameron, Chief Revenue Officer di Axon Enterprise, ha dichiarato una transazione in data 02/09/2025 con la cessione di 749 azioni ordinarie di Axon. Il Modulo 4 indica che le azioni sono state trattenute per coprire la passività fiscale derivante dal vesting di restricted stock unit, al prezzo di $747,29 per azione. Dopo la ritenuta, la persona segnalante possedeva beneficiariamente 18.698 azioni, detenute direttamente. Il modulo è stato firmato da un procuratore il 03/09/2025. Non sono riportate altre transazioni né posizioni in derivati.

Brooks Cameron, Chief Revenue Officer de Axon Enterprise, informó una transacción el 02/09/2025 por la enajenación de 749 acciones ordinarias de Axon. El Formulario 4 indica que las acciones fueron retenidas para cubrir la obligación fiscal derivada del otorgamiento (vesting) de unidades de acciones restringidas, a un precio de $747,29 por acción. Tras la retención, la persona informante poseía beneficiariamente 18.698 acciones, en posesión directa. El formulario fue firmado por un apoderado el 03/09/2025. No se informan otras transacciones ni posiciones sobre derivados.

Axon Enterprise의 최고매출책임자(CRO) Brooks Cameron은 2025-09-02에 Axon 보통주 749주를 처분한 거래를 보고했습니다. Form 4에는 해당 주식이 제한주식단위(RSU)의 베스팅으로 발생한 세금 부담을 충당하기 위해 원천징수된 것이며, 주당 가격은 $747.29로 기재되어 있습니다. 원천징수 후 보고인은 18,698주직접 보유한 것으로 나타났습니다. 해당 서류는 2025-09-03에 대리인이 서명했습니다. 다른 거래나 파생상품 포지션은 보고되지 않았습니다.

Brooks Cameron, Chief Revenue Officer d’Axon Enterprise, a déclaré une transaction en date du 02/09/2025 portant sur la cession de 749 actions ordinaires d’Axon. Le formulaire 4 précise que les actions ont été retenues pour couvrir la charge fiscale liée au vesting d’unités d’actions restreintes, au prix de 747,29 $ par action. Après la retenue, la personne déclarante détenait à titre bénéficiaire 18 698 actions, détenues directement. Le formulaire a été signé par un mandataire le 03/09/2025. Aucune autre transaction ni position sur dérivés n’est déclarée.

Brooks Cameron, Chief Revenue Officer von Axon Enterprise, meldete am 02.09.2025 eine Transaktion über die Veräußerung von 749 Aktien der Axon-Stammaktien. Im Formular 4 wird angegeben, dass die Aktien einbehalten wurden, um die steuerliche Verpflichtung aus dem Vesting von Restricted Stock Units zu begleichen, zum Preis von $747,29 pro Aktie. Nach der Einbehaltung besaß die meldende Person wirtschaftlich 18.698 Aktien, die direkt gehalten werden. Das Formular wurde am 03.09.2025 von einem Bevollmächtigten unterschrieben. Es werden keine weiteren Transaktionen oder Derivatepositionen gemeldet.

Positive
  • Disposition was for tax withholding relating to RSU vesting rather than an open-market sale
  • Reporting person retains direct ownership of 18,698 shares after the withholding
Negative
  • None.

Insights

TL;DR: Routine RSU tax withholding, not an open-market sale; minimal governance signal.

The Form 4 documents a common administrative disposition where restricted stock units vest and a portion is withheld to cover taxes. This does not represent a discretionary open-market sale or a change in director/officer alignment. The reporting person remains a direct holder of 18,698 shares, and the filing identifies the role as Chief Revenue Officer. From a governance perspective, such filings are routine and do not indicate compensation policy changes or extraordinary insider liquidity.

TL;DR: Disposal was tax-related at $747.29 per share; transaction size is small relative to typical insider holdings.

The transaction code and explanatory note clarify the 749-share disposition resulted from tax withholding upon RSU vesting, executed at $747.29 per share on 09/02/2025. The remaining direct ownership of 18,698 shares is disclosed. There are no derivative transactions reported. For investors monitoring insider selling, this is a routine, non-dispositive event and provides limited insight into management’s view of the stock.

Brooks Cameron, Chief Revenue Officer di Axon Enterprise, ha dichiarato una transazione in data 02/09/2025 con la cessione di 749 azioni ordinarie di Axon. Il Modulo 4 indica che le azioni sono state trattenute per coprire la passività fiscale derivante dal vesting di restricted stock unit, al prezzo di $747,29 per azione. Dopo la ritenuta, la persona segnalante possedeva beneficiariamente 18.698 azioni, detenute direttamente. Il modulo è stato firmato da un procuratore il 03/09/2025. Non sono riportate altre transazioni né posizioni in derivati.

Brooks Cameron, Chief Revenue Officer de Axon Enterprise, informó una transacción el 02/09/2025 por la enajenación de 749 acciones ordinarias de Axon. El Formulario 4 indica que las acciones fueron retenidas para cubrir la obligación fiscal derivada del otorgamiento (vesting) de unidades de acciones restringidas, a un precio de $747,29 por acción. Tras la retención, la persona informante poseía beneficiariamente 18.698 acciones, en posesión directa. El formulario fue firmado por un apoderado el 03/09/2025. No se informan otras transacciones ni posiciones sobre derivados.

Axon Enterprise의 최고매출책임자(CRO) Brooks Cameron은 2025-09-02에 Axon 보통주 749주를 처분한 거래를 보고했습니다. Form 4에는 해당 주식이 제한주식단위(RSU)의 베스팅으로 발생한 세금 부담을 충당하기 위해 원천징수된 것이며, 주당 가격은 $747.29로 기재되어 있습니다. 원천징수 후 보고인은 18,698주직접 보유한 것으로 나타났습니다. 해당 서류는 2025-09-03에 대리인이 서명했습니다. 다른 거래나 파생상품 포지션은 보고되지 않았습니다.

Brooks Cameron, Chief Revenue Officer d’Axon Enterprise, a déclaré une transaction en date du 02/09/2025 portant sur la cession de 749 actions ordinaires d’Axon. Le formulaire 4 précise que les actions ont été retenues pour couvrir la charge fiscale liée au vesting d’unités d’actions restreintes, au prix de 747,29 $ par action. Après la retenue, la personne déclarante détenait à titre bénéficiaire 18 698 actions, détenues directement. Le formulaire a été signé par un mandataire le 03/09/2025. Aucune autre transaction ni position sur dérivés n’est déclarée.

Brooks Cameron, Chief Revenue Officer von Axon Enterprise, meldete am 02.09.2025 eine Transaktion über die Veräußerung von 749 Aktien der Axon-Stammaktien. Im Formular 4 wird angegeben, dass die Aktien einbehalten wurden, um die steuerliche Verpflichtung aus dem Vesting von Restricted Stock Units zu begleichen, zum Preis von $747,29 pro Aktie. Nach der Einbehaltung besaß die meldende Person wirtschaftlich 18.698 Aktien, die direkt gehalten werden. Das Formular wurde am 03.09.2025 von einem Bevollmächtigten unterschrieben. Es werden keine weiteren Transaktionen oder Derivatepositionen gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brooks Cameron

(Last) (First) (Middle)
17800 NORTH 85TH STREET

(Street)
SCOTTSDALE AZ 85255

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF REVENUE OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 F(1) 749 D $747.29 18,698 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Securities disposed represent securities withheld to settle the reporting person's tax liability resulting from the vesting of restricted stock units.
Remarks:
/s/ Cameron Brooks by Isaiah Fields, Attorney-in-Fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AXON insider Brooks Cameron do on 09/02/2025?

The Form 4 shows 749 shares were disposed on 09/02/2025 via withholding to satisfy taxes from RSU vesting at $747.29 per share.

Why were the 749 shares disposed according to the Form 4?

The explanatory note states the shares were withheld to settle the reporting person's tax liability resulting from restricted stock unit vesting.

How many AXON shares does Brooks Cameron beneficially own after the transaction?

The filing reports 18,698 shares beneficially owned following the reported transaction, held directly.

Was this transaction an open-market sale?

No; the Form 4 indicates the shares were withheld to satisfy taxes from RSU vesting, not sold in the open market.

Who signed the Form 4 and when?

The Form 4 was signed by /s/ Cameron Brooks by Isaiah Fields, Attorney-in-Fact on 09/03/2025.
Axon Enterprise

NASDAQ:AXON

AXON Rankings

AXON Latest News

AXON Latest SEC Filings

AXON Stock Data

57.32B
75.22M
4.19%
83.45%
1.84%
Aerospace & Defense
Ordnance & Accessories, (no Vehicles/guided Missiles)
Link
United States
SCOTTSDALE